Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scintigraphic Assessment of Nasal Deposition and Clearance of 99mTc DTPA Ketorolac Solution Administered Using the Valois Nasal Spray Device

NCT01356212 is registered in ClinicalTrials.gov with Egalet Ltd as lead sponsor.

NCT NCT01356212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scintigraphic Assessment of Nasal Deposition and Clearance of 99mTc DTPA Ketorolac Solution Administered Using the Valois Nasal Spray Device
Lead sponsor
Egalet Ltd
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2002
Completion date
December 31, 2002
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects